NxStage MDS Corporation recalls NxStage Cartridge Express with Speedswap, Catalog No. CAR-535. An accessory device for facilitating the removal and rep…
- Recall date
- January 29, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1191-2024
- FDA classification
- Class II
- Brand / firm
- NxStage MDS Corporation
- Sold / distributed
- US domestic distribution to Dialysis Centers located in AZ, CA, CO, GA, IL, IN, MA, MD, MI, MN, MO, MS, NC, NJ, NY, TN, TX, VA, WI. No international distribution.
Why it was recalled
Product is recalled due to reports of blood leaking or spraying from the arterial line on the cartridge.If this failure occurs, a patient may experience uncontrolled blood loss or a healthcare professional could be exposed to infectious patient blood.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NxStage Cartridge Express with Speedswap, Catalog No. CAR-535. An accessory device for facilitating the removal and replacement of a flow-compromised filter during treatment of acute and chronic renal failure or fluid overload.
Get recall alerts
Free email alert whenever NxStage MDS Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NxStage MDS Corporation